CDI

Clinical trials for CDI explained in plain language.

Never miss a new study

Get alerted when new CDI trials appear

Sign up with your email to follow new studies for CDI, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Could a cocktail of good bacteria break the cycle of c. diff?

Disease control Recruiting now

This large Phase 3 trial tests whether VE303, a capsule containing 8 harmless bacteria, can prevent repeat Clostridioides difficile (C. diff) infections. About 852 people who have had at least one prior C. diff infection will take VE303 or a placebo for 14 days. The main goal is …

Matched conditions: CDI

Phase: PHASE3 • Sponsor: Vedanta Biosciences, Inc. • Aim: Disease control

Last updated Jul 29, 2026 00:00 UTC

CDI

Get alerted when new CDI trials appear

Could a cocktail of good bacteria break the cycle of c. diff?